• Mashup Score: 2

    Health|Hospitalizations of young children with the virus surged during the U.S. Omicron wave.https://www.nytimes.com/2022/03/21/health/hospitalizations-of-young-children-with-the-virus-surged-during-the-us-omicron-wave.htmlCredit…Erin Schaff/The New York TimesBabies and children younger than age 5 were hospitalized with coronavirus at much higher rates during the latest U.S. surge, when the…

    Tweet Tweets with this article
    • Children under age 5, none of whom are yet elig to #GetVaccinated, were 5 times more likely to be hospitalized during the #Omicron surge than during #DeltaVariant, & 2/3 had no underlying medical conditions. Please #WearAMask to protect them. https://t.co/7qSFFv002a

  • Mashup Score: 39

    A test-negative case control analysis using data from a diverse population in California, USA, demonstrates that vaccine efficacy of a three-dose regimen of the mRNA-1273 COVID-19 vaccine is reduced against infection with the Omicron SARS-CoV-2 variant compared with Delta, but that efficacy against hospitalization remained high for both variants.

    Tweet Tweets with this article
    • Lrg test-neg case-control study finds 3 doses of Moderna vaccine >99% protective vs hospitalization from #DeltaVariant or #Omicron. Vaccine protection vs infxn was lower, esp in #immunocompromised ppl (only 29% efficacy for them vs Omicron). #OncTwitter https://t.co/59PqH1Fq9F https://t.co/OXzXghoxjr

  • Mashup Score: 9

    The Food and Drug Administration is curbing the use of two out of three monoclonal antibody treatments because new data shows they aren’t effective against the omicron variant.

    Tweet Tweets with this article
    • #Omicron (🟣) is now 99.8% of all cases of #COVID19 in the US, almost totally eliminating #DeltaVariant (🟠). This is why the FDA halted use of 2 brands of monoclonal antibodies that worked well vs Delta but aren’t effective against Omicron. #MedTwitter https://t.co/xxI597jIH0 https://t.co/LxV5eMctlh

  • Mashup Score: 95

    This report describes COVID-19 vaccine effectiveness time frames among people who received their first and second doses of the vaccine series, and effectiveness of third vaccine doses during both Delta- and Omicron-predominant periods.

    Tweet Tweets with this article
    • NEW: Today's @CDCMMWR study found that during periods of both #DeltaVariant and #OmicronVariant, a 3rd dose was highly effective at preventing #COVID19 associated emergency department visits, urgent care visits & hospitalizations. https://t.co/X8chSXviW7 https://t.co/OMtvSgZU1J

  • Mashup Score: 0

    Humoral and cellular immune responses after standard two-dose COVID-19 vaccination are reduced in immunosuppressed patients with antineutrophil cytoplasmic antibodies associated vasculitis (AAV).1–3 Emerging variants such as B.1.617.2 (delta) are of particular concern because of their higher transmissibility and partial immune escape.4 AAV patients with lower neutralising antibody levels may…

    Tweet Tweets with this article
    • Effect of a third dose in ANCA-associated #vasculitis? ▶️ patients may not be protected against #deltavariant with a standard 2-doses regimen ▶️ a third dose induced a strong antibody activity against delta in most patients, but not in those w/rituximab 🔗 https://t.co/suaRhH0Nf0 https://t.co/5q1xLj8xrw